Pharma & Bio
Technology
Three Strategies to Boost Corporate Value… “Technology Exports, Pet Products, and IPOs” [In-Depth Look at Glasseum ③]
Glasseum is currently known as a company developing treatments for Parkinson’s disease. However, a closer look at the company’s business structure reveals that its strategy is not to stake everything …
Technology
“Alpha-Synuclein Leads to Parkinson’s Disease”…Proposing a Different Solution from Big Pharma [In-Depth Look at Glaseum ②]
The Parkinson’s disease treatment market has been facing the same limitations for decades. Currently available drugs only alleviate symptoms; they do not halt the progression of the disease itself. As…
Technology
“Why Do We Gain Weight as We Age?”… Why CEO Yoo Sang-gu Is Obsessed with Autophagy [In-Depth Look at Glaseum ①]
Obesity and Parkinson’s disease appear to be completely different conditions—one is a metabolic disorder, while the other is a degenerative brain disease. However, Glaseum links these two conditions t…
Technology
3billion Inc.: Will It Strike Gold in Texas? Expectations for a Return to Profitability Next Year
#3billion Inc. has declared next year to be the “first year of revenue growth.” Following a more than twofold increase in operating revenue to 11.7 billion won in 2025 compared to the previous year, t…
Lifestyle
TiumBio Co., Ltd.’s Tosposertib: Why It Can Survive Even the ‘Clinical Graveyard’ of TGF-β
TiumBio Co., Ltd.(321550)Tium Bio appears to be one step closer to becoming “first-in-class” as it accelerates clinical trials of “Tosfosetip,” which works by blocking TGF-β. Although there have been …
Technology
Lilly Buys Another BBB Platform… What Will Be the Impact on ABL Bio?
Competition in the blood-brain barrier (BBB) delivery platform sector is intensifying as Eli Lilly has secured the BBB shuttle platform of Swedish biotech firm BioArctic, following its acquisition of …
Lifestyle
Lemon Healthcare's Wild Debut, Vivozon's Clinical Boost [K-bio pulse]
On July 6, the pharmaceutical and biotechnology sector saw newly listed Lemon Healthcare experience a rollercoaster ride, surging early in the session before plummeting. PeopleBio rose on the back of …
Lifestyle
LEMON COMPANY LIMITED Rides a Roller Coaster on Its First Day of Trading… High Hopes for Vivzon’s Clinical Trials [Bio Spotlight]
On the 6th, the pharmaceutical and biotech sector saw a rollercoaster ride, with #LemonHealthcare—which went public that day—soaring before plummeting. PeopleBio, Inc.(304840)rose on the back of concr…
Technology
A Look at the Track Record of Underwriters for Rokit Healthcare’s U.S. IPO... 88% Traded Below the Offering Price
Rokit Healthcare is drawing significant attention amid expectations that its subsidiary, Rokit America, will list on the U.S. Nasdaq. On the 24th of last month, news that Rokit America had entered the…
Lifestyle
"Equipped with a Merck Partnership and Innovation Platform": What Are the Opportunities and Risks for Ingenia?
INGENIA Therapeutics (hereinafter “INGENIA”), considered a promising contender in the initial public offering (IPO) market for the second half of this year, has received approval for its preliminary l…